Clear Admit MBA Fair 2025 in Boston, May 14th
One Night, 25 Elite MBA Programs: Clear Admit's Must-Attend Fair Hits Boston This May
This highly anticipated event offers prospective MBA applicants a unique opportunity to connect directly with admissions officers from 25 top-ranked business schools, network with alumni, and gather valuable insights into the MBA application journey.
Participating schools include Harvard Business School, MIT Sloan, Stanford GSB, Columbia Business School, Chicago Booth,
In addition to the fair, attendees will benefit from a lineup of live, interactive panel discussions featuring admissions professionals, MBA alumni, and industry leaders.
Panel Schedule:
5:20 –
5:50 –
6:20 –
6:55 –
7:25 –
The 2025 MBA Fair is hosted in collaboration with GMAC, Leland, and Juno, who will also be onsite to offer expert advice and support.
The event is free to attend, but registration is required and space is limited. Secure your spot today: https://hubs.la/Q03hFmf30
About Clear Admit:
Clear Admit is a leading online resource and community for MBA applicants. With school-specific admissions news, application tips, and tools like LiveWire and ApplyWire, Clear Admit supports prospective students throughout their business school journey.
For press inquiries or additional information, please contact:
Victoria Pusiankova
Marketing Specialist, Clear Admit
[email protected]
www.clearadmit.com
This press release was issued through 24-7PressRelease.com. For further information, visit http://www.24-7pressrelease.com.
View original content to download multimedia:https://www.prnewswire.com/news-releases/clear-admit-mba-fair-2025-in-boston-may-14th-302447708.html
SOURCE Clear Admit
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Accro Bioscience Announces Inclusion of AC-101 tablets in the NMPA CDE's "Caring Plan-Extension" Pilot Program for Rare Disease Drug Development
- Breaking into the Global Top Three for Premium Displays, Chinese Smartphone Brand iQOO Set to Unveil a Breakthrough Display Product
- Whitehawk Therapeutics Presents Real-World Analyses Supporting PTK7 as a Durable ADC Target in EGFR Wild-Type Non-Small Cell Lung Cancer at WCLC 2026
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
GMACSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share